Prognostic impact of depth of response (DpR) and early tumour shrinkage (ETS) in patients (pts) with BRAF V600E mutated (mut) metastatic colorectal cancer (mCRC) receiving targeted therapy (TT) as second-line treatment

Annals of Oncology(2023)

引用 0|浏览2
暂无评分
关键词
metastatic colorectal cancer,early tumour shrinkage,prognostic impact,mcrc,second-line
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要